# US 2012/0252059 A1 · Fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252059 A1
- Document ID: US20120252059A1
- Status: Published application
- Kind: A1
- Application number: 13/493,556
- Filed: 2012-06-11
- Published: 2012-10-04
- Earliest claimed: 2007-07-26
- Assignees: Pierre Fabre Medicament
- Inventors: Jean-Philippe Annereau; Jean-Marc Barret; Yves Guminski; Thierry Imbert
- Web page: https://patentgrep.com/patent/US20120252059A1

## CPC

- C07D 271/12: condensed with carbocyclic rings or ring systems
- A61P 35/00: Antineoplastic agents
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to novel fluorescent derivatives of polyamines having a benzoxadiazole group, to a method for preparing the same and to the use thereof as diagnosis tools for emphasising the polyamine transport system in cancerous cells in order to adapt the treatment thereof, and thus for selecting patients carrying such tumours in order to adapt their treatment. The derivatives are of the formula (I) or a pharmaceutically acceptable salt thereof, in which: R1 is one or more NO2 groups in position 4 or 6, or a SO2Ph, SO2NMe2, SO2NH2 or SO3H group; R2 is hydrogen, C1-6 alkyl, benzyl, a perfluoroalkyl group; the values of a, b, c range from 2 to 5 independently from each other and represent alkylene chains separating the amino groups, and the values of d and e can independently be 0 or 1.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A method for detecting tumours expressing the polyamine transport system using as diagnostic fluorescent probe a compound of general formula 1:
or a pharmaceutically acceptable salt thereof,
in which:
R1 represents one or two NO2 groups at position 4 and/or 6, or a SO2Ph, SO2NMe2, SO2NH2, or SO3H group; Formula 1
the polyamine chain can be at position 5, 6 or 7;
R2 represents a hydrogen, a C1-6alkyl, a benzyl, or a perfluoroalkyl group;
the values of a, b, and c can be 2 to 5, independently of each other, and represent alkylene chains separating the amino groups;
the values of d and e may be 0 or 1 independently, but cannot represent value 0 at the same time.

### Claim 15 (depends on 14)

The method according to claim 14, wherein R1 represents one or two NO2 groups at position 4 and/or 6.

### Claim 16 (depends on 15)

The method according to claim 15, wherein R1=4-NO2.

### Claim 17 (depends on 14)

The method according to claim 14, wherein R1=4-NO2, R2=C1-6alkyl, a=3, b=4, c=3, and d=e=1.

### Claim 18 (depends on 14)

The method according to claim 14, wherein R1=4-NO2, R2=H or C1-6alkyl, a=0, b=4, c=3, d=0, and e=1.

### Claim 19 (depends on 14)

The method according to claim 14, wherein R1=R2=H or C1-6alkyl, a=0, b=3, c=4, d=0, and e=1.

### Claim 20 (depends on 14)

The method according to claim 14, wherein R1=4-NO2, R2=C1-6alkyl, a=4, b=0, c=0, d=1, and e=0.

### Claim 21 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N-(3-aminopropyl)-N′-{3-[methyl-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)-amino]-propyl}-butane-1,4-diamine.

### Claim 22 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N-(3-aminopropyl)-N′-methyl-N′-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)-butane-1,4-diamine.

### Claim 23 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N-(3-aminopropyl)-N′-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)-butane-1,4-diamine.

### Claim 24 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N*1*-{3-[methyl-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)-amino]-propyl}-butane-1,4-diamine.

### Claim 25 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N*1*-[3-(7-nitrobenzo[1,2,5]oxadiazol-4-yl-amino)-propyl]-butane-1 diamine.

### Claim 26 (depends on 14)

The method according to claim 14, wherein the compound of formula (I) is N*1*-methyl-N*1*-(7-nitrobenzo[1,2,5]oxadiazol-4-yl)-butane-1,4-diamine.
